0.35Open0.51Pre Close90 Volume147 Open Interest82.00Strike Price7.00KTurnover53.75%IV4.21%PremiumDec 6, 2024Expiry Date0.00Intrinsic Value100Multiplier3DDays to Expiry0.65Extrinsic Value100Contract SizeAmericanOptions Type0.2686Delta0.0811Gamma122.02Leverage Ratio-0.2133Theta0.0019Rho32.77Eff Leverage0.0250Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
Great products sells itself, ask novo disk and how they sell ozempic
No comment yet